MedTrace Logo

COOL-Trial: Outcome With Invasive and Non-invasive Cooling After Cardiac Arrest

NCT00843297 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2010-02-02

No results posted yet for this study

Summary

Sudden cardiac arrest (SCA) remains one of the major leading causes of death. Cognitive deficits are common in survivors of SCA. Postresuscitative mild induced hypothermia (MIH) lowers mortality and reduces neurologic damage after cardiac arrest. The investigators evaluated the efficacy and side effects of therapeutic hypothermia in an unselected group of patients after SCA.

Conditions

  • Cardiac Arrest
  • Hypothermia

Interventions

DEVICE

Coolgard

invasive Cooling via femoral ICY-catheter

DEVICE

ArcticSun

Noninvasive surface-cooling by saline-cooled thermo-vest

OTHER

Conventional treatment

Intensive care-treatment without cooling

Sponsors & Collaborators

  • University of Leipzig

    lead OTHER

Principal Investigators

  • Holger Thiele, Associate Professor · Study Chair

  • Undine Pittl, MD · Study Sub-Investigator

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-12-31
Completion
2010-01-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00843297 on ClinicalTrials.gov